Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 1,750 shares at $25.34 ($45K) on 2024-05-16, disclosed to the SEC on 2024-05-20.
Scheduled sale ($45k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.34 | 1,283 | $33K | 73.0% |
| 2 | $25.75 | 467 | $12K | 27.0% |
| Total | $25.45 avg | 1,750 | $45K | 100% |
| Filing → |
| FDMT | SELL | 2026-08-17 | $40K | — | Filing → |
| FDMT | SELL | 2026-07-02 | $92K | — | Filing → |
| FDMT | SELL | 2026-06-25 | $118K | — | Filing → |